Approximately 10.5% of medicines in low and middle income countries including India are sub-standard and falsified, said WHO in this report.
[2]This report has grown out of the work of the GSMS, which provides national regulatory authorities with an interconnected network. This allows them, for the first time, to cross-reference reports of suspect products with those reported from other regions by searching the WHO database and accessing photograph libraries of confirmed substandard and falsified products.
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/reports-documents/who-global-surveillance-and-monitoring-system-substandard-and-falsified-medical
[2] http://www.indiaenvironmentportal.org.in/files/file/substandard medical products.pdf
[3] http://admin.indiaenvironmentportal.org.in/category/publisher/world-health-organization
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/antibiotic
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-effects
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/statistics
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/pakistan
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/pneumonia
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/malaria
[12] http://admin.indiaenvironmentportal.org.in/category/thesaurus/paraguay
[13] http://admin.indiaenvironmentportal.org.in/category/thesaurus/africa
[14] http://admin.indiaenvironmentportal.org.in/category/thesaurus/global
